Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease

doi:10.3748/wjg.v22.i34.7718

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 34

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8984)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

647

WORD

323

HTML

5663

Figures (1-2)

274

Tables (1-1)

150

Sum=7057

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

914

Download

1013

Sum=1927

Sep 14, 2016 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (36)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Sep 14, 2016; 22(34): 7718-7726
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7718

Full Size Figure Download Figure

Figure 1 Various types of complex NPs for oral drug delivery. A: pH-sensitive NP; B: NiMOS; C: NPs in hydrogel; D: ROS-sensitive NP.

Citation: Si XY, Merlin D, Xiao B. Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease. World J Gastroenterol 2016; 22(34): 7718-7726
URL: https://www.wjgnet.com/1007-9327/full/v22/i34/7718.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i34.7718